# National Resilience

National Resilience is a biomanufacturing based in Somerville, United States.

## Overview

- **Organization type:** biomanufacturing
- **Headquarters:** Somerville, United States
- **Region:** North America
- **Address:** Somerville, MA, United States
- **Founded:** 2020
- **Assets under management:** Undisclosed
- **Website:** resilience.com
- **LinkedIn:** https://www.linkedin.com/company/national-resilience

## Regulatory record

- **Reports private funds:** No

## About

National Resilience was founded in 2020 by Rahul Singhvi, a former executive at Johnson & Johnson and Merck, alongside Harvard professor Gary Pisano as board chair. The company raised over $800M in its first two years from a syndicate that included ARCH Venture Partners, CPP Investments, and the Alaska Permanent Fund (per The Wall Street Journal, 2021). Its founding premise: the COVID-19 pandemic had exposed a dangerous over-reliance on offshore contract manufacturing for critical medicines. The firm does not invest in drug discovery — it builds and operates Good Manufacturing Practice (GMP) facilities that produce biologics, vaccines, and gene therapies for biotech and pharmaceutical customers. Confirmed facilities include a campus in Alachua, Florida, and a partnership with the US Department of Defense to manufacture pandemic-response vaccines. Resilience also acquired the Boston-area manufacturing operations of Sanofi in 2021 to expand its capacity (per Sanofi press release, 2021). Resilience employs more than a dozen PhD-level scientists and operates facilities in Massachusetts, Florida, Quebec, and California. In March 2023, the company announced a strategic collaboration with the US Biomedical Advanced Research and Development Authority (BARDA) to build an integrated manufacturing network for medical countermeasures (per BARDA, March 2023). Resilience's structural differentiator is its focus on end-to-end biomanufacturing rather than drug development — it operates as a services company, not a therapeutics firm. That model means it does not compete with its own customers for product revenues, and it can serve multiple sponsors from a single facility. Its success will turn on whether it can maintain high utilization rates and GMP compliance across a distributed network of aging pharma plants.

## Sectors

- Biotech & Pharma
- BioManufacturing
- Supply Chain

## Offices

- New York, NY, United States
- Boston, MA, United States
- Montreal, QC, Canada
- Cambridge, MA, United States

## People

- Rahul Singhvi — Chief Executive Officer
- Gary Pisano — Chairman of the Board

## Questions

### Who controls the strategic direction at National Resilience?

CEO Rahul Singhvi, a former J&J and Merck executive, sets strategy alongside a board chaired by Gary Pisano, the Harvard Business School professor. The board includes representatives from lead investors ARCH Venture Partners and CPP Investments.

### Does National Resilience develop its own drug candidates?

No. Resilience explicitly operates as a contract development and manufacturing organization (CDMO), not a drug developer. Its revenue comes from manufacturing fees, not product sales or milestones.

### Which government entities has Resilience worked with?

Resilience received funding and partnership designations from the U.S. Department of Defense and BARDA. In March 2023, BARDA awarded the company a contract to support manufacturing of medical countermeasures (per BARDA, March 2023).

### What types of therapies does Resilience manufacture?

Resilience focuses on biologics, including monoclonal antibodies, vaccines, gene therapies, and other recombinant proteins. It does not handle small-molecule drugs or generics.

### What is the firm's geographic footprint?

Resilience operates facilities in Somerville, Massachusetts (headquarters); Alachua, Florida; Boston, Massachusetts; and Montreal, Quebec. It also maintains offices in San Diego, California, and Cambridge, Massachusetts (per Resilience company materials).

## Related profiles

- [E. Sun Financial](https://altss.com/profile/e-sun-financial)
- [Home Credit Venture Capital](https://altss.com/profile/home-credit-venture-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/national-resilience

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology